MannKind Regains Afrezza® Marketing Rights
April 05, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) has assumed responsibility for the worldwide development and commercialization of Afrezza®...
MannKind Corporation Reports 2015 Fourth Quarter and Full Year Financial Results
March 14, 2016 16:48 ET
|
MannKind
VALENCIA, Calif., March 14, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2015.For...
MannKind Announces Appointment of Michael Castagna as Chief Commercial Officer
March 14, 2016 16:00 ET
|
MannKind
VALENCIA, Calif., March 14, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced that Michael E. Castagna, Pharm.D., has joined the company as its Chief...
MannKind Corporation to Hold 2015 Fourth Quarter and Full Year Financial Results Conference Call on March 14, 2016
March 07, 2016 18:15 ET
|
MannKind
VALENCIA, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) will release its 2015 fourth quarter and full year financial results on Monday, March 14, 2016...
MannKind to Potentially File 2015 10-K Filing Extension
February 26, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today announced that it anticipates being unable to timely file its Annual Report on Form 10-K...
MannKind Mourns the Passing of Chairman Emeritus Alfred E. Mann
February 26, 2016 08:00 ET
|
MannKind
VALENCIA, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today reported with deep sadness the passing of Alfred E. Mann, age 90, the company’s Chairman...
Alfred Mann Steps Down as Executive Chairman of Mannkind
February 19, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., Feb. 19, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced that on February 17, 2016 MannKind received notice from Alfred E. Mann that he...
MannKind Corporation to Present at the RBC Capital Markets 2016 Healthcare Conference
February 16, 2016 17:00 ET
|
MannKind
VALENCIA, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), focused on the discovery and development of therapeutic products for diabetes, announced today...
MannKind Corporation to Hold Investor Conference Call on February 3, 2016
January 27, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., Jan. 27, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) will host a conference call to discuss Company developments at 5:00 PM (Eastern Time) on...
MannKind Enters Into Collaboration and License Agreement
January 21, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., Jan. 21, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today announced that it has entered into a collaboration and license agreement with a newly...